These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 6129997)
21. [Effect of indomethacin on the development of cardiac and hemodynamic disorders in shock of immune origin]. Sagach VF Farmakol Toksikol; 1987; 50(3):104-6. PubMed ID: 2440716 [TBL] [Abstract][Full Text] [Related]
22. [The effects of nicardipine on hemodynamics, regional myocardial function and myocardial metabolism in the dog with coronary artery occlusion]. Nomura H; Ogawa S; Yasuma F; Narita G; Miyaguchi K; Hama Y; Sotobata I Kokyu To Junkan; 1987 Oct; 35(10):1079-85. PubMed ID: 3423440 [No Abstract] [Full Text] [Related]
23. Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA). Zhao L; Kirsch CC; Hagen SR; Elliott GT J Mol Cell Cardiol; 1996 Jan; 28(1):197-208. PubMed ID: 8745227 [TBL] [Abstract][Full Text] [Related]
24. Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction. Min JY; Sandmann S; Meissner A; Unger T; Simon R J Pharmacol Exp Ther; 1999 Dec; 291(3):1038-44. PubMed ID: 10565822 [TBL] [Abstract][Full Text] [Related]
25. [Effect of sodium oxybutyrate on the blood supply and activity of the normal and ischemic myocardium]. Chichkanov GG; Bogolepov AK; Tsorin IB; Matsievskiĭ DD Biull Eksp Biol Med; 1982 Mar; 93(3):44-7. PubMed ID: 7093482 [TBL] [Abstract][Full Text] [Related]
26. [Metabolic and hemodynamic aspects of the effect of inosine in cardiac damage of immunologic origin]. Moibenko AA; Frantsuzova SB; Sagach VF; Korkach VI; Marchenko GI Patol Fiziol Eksp Ter; 1986; (4):23-6. PubMed ID: 3797069 [No Abstract] [Full Text] [Related]
27. [The subcellular pathophysiology of heart failure due to toxic-allergic myocarditis and the action of refracterin on intracardiac hemodynamics and the functional state of the 3 subcellular cardiomyocyte systems responsible for the act of contraction-relaxation]. Karsanov NV; Sukoian GV; Dzhibgashvili IK; Tatulashvili DR; Gorelishvili II; Guchua EI Patol Fiziol Eksp Ter; 1999; (3):3-8. PubMed ID: 10498985 [TBL] [Abstract][Full Text] [Related]
28. [The efficacy of quinazopyrine, preparation E and riboxin in experimental myocardial infarct]. Stets VR; Tishkin VS; Evdokimov EI Vrach Delo; 1989 Dec; (12):13-4. PubMed ID: 2483471 [TBL] [Abstract][Full Text] [Related]
30. Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment. Sanbe A; Tanonaka K; Niwano Y; Takeo S J Pharmacol Exp Ther; 1994 Apr; 269(1):51-6. PubMed ID: 8169851 [TBL] [Abstract][Full Text] [Related]
31. [Experience with a new Soviet antihistaminic drug, phencarol, in dermatology]. Borisenko KK; Butov IuS; Korotkiĭ NG; Abaeva AS Vestn Dermatol Venerol; 1977 Apr; (4):72-5. PubMed ID: 19900 [No Abstract] [Full Text] [Related]
32. [The cardioprotective action of preparations of biotechnological cytochrome c in acute myocardial ischemia]. Gatsura VV; Sernov LN; Davidov ER Eksp Klin Farmakol; 1998; 61(2):27-9. PubMed ID: 9621169 [TBL] [Abstract][Full Text] [Related]
33. [Cardio- and hemodynamics of dogs in exposure of the heart to immune complexes]. Sagach VF; Shablovskaia OV Biull Eksp Biol Med; 1985 May; 99(5):549-52. PubMed ID: 4005408 [TBL] [Abstract][Full Text] [Related]
34. [Experimental study of the antiedema activity of antihistamine preparations compared to the dynamics of their concentration in the blood serum]. Kholodov LE; Kaverina LP; Dorokhov VV Farmakol Toksikol; 1985; 48(1):43-5. PubMed ID: 2858404 [TBL] [Abstract][Full Text] [Related]
35. [Effect of the antihistamine preparation, phencarol, on the central nervous system]. Kaminka ME; Roshchina LF; Mashkovskiĭ MD Farmakol Toksikol; 1980; 43(2):148-53. PubMed ID: 6108233 [TBL] [Abstract][Full Text] [Related]
36. [Effect of phencarol on pancreatic digestive enzymes in food anaphylaxis]. Ismailov SR Eksp Klin Farmakol; 2001; 64(3):48-9. PubMed ID: 11558439 [TBL] [Abstract][Full Text] [Related]
37. [Effect of vitamin E on the energy allowance of functional and plastic processes in the myocardium during ischemia and reoxygenation]. Artamonov SD; Danilov MA; Kirpatovskiĭ VI; Burdina GV; Onishchenko NA Farmakol Toksikol; 1988; 51(3):27-30. PubMed ID: 3410022 [TBL] [Abstract][Full Text] [Related]
38. Contractility and energetics effects of ethanol and isoproterenol using an improved biologically stable isolated ejecting rat heart system. Segel LD; Woliner M; Miller RR; Amsterdam EA; Chacko KJ; Drake C; Stoll PJ; Mason DT Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):555-73. PubMed ID: 897346 [No Abstract] [Full Text] [Related]
39. [Treatment of pollen-induced hay fever with a new antihistaminic preparation phencarol]. Voronkin VF; Chekanova OA Vestn Otorinolaringol; 1980; (6):55-8. PubMed ID: 6109389 [No Abstract] [Full Text] [Related]
40. Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs. Hennan JK; Swillo RE; Morgan GA; Keith JC; Schaub RG; Smith RP; Feldman HS; Haugan K; Kantrowitz J; Wang PJ; Abu-Qare A; Butera J; Larsen BD; Crandall DL J Pharmacol Exp Ther; 2006 Apr; 317(1):236-43. PubMed ID: 16344331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]